` BLAU3 (Blau Farmaceutica SA) vs BOVESPA Comparison - Alpha Spread

BLAU3
vs
B
BOVESPA

Over the past 12 months, BLAU3 has underperformed BOVESPA, delivering a return of +9% compared to the BOVESPA's +12% growth.

Stocks Performance
BLAU3 vs BOVESPA

Loading
BLAU3
BOVESPA
Add Stock

Performance Gap
BLAU3 vs BOVESPA

Loading
BLAU3
BOVESPA
Difference
www.alphaspread.com

Performance By Year
BLAU3 vs BOVESPA

Loading
BLAU3
BOVESPA
Add Stock

Competitors Performance
Blau Farmaceutica SA vs Peers

BOVESPA
BLAU3
ABBV
AMGN
GILD
VRTX
Add Stock

Blau Farmaceutica SA
Glance View

Market Cap
2.3B BRL
Industry
Biotechnology

Blau Farmacêutica SA engages in the manufacturing of pharmaceuticals. The company is headquartered in Cotia, Sao Paulo and currently employs 1,700 full-time employees. The company went IPO on 2021-04-19. The firm focuses on the development, production and commercialization of medicines, which aim at treatment in the areas of oncology, nephrology, hematology and infectology, among others. Its product lines includes biopharmaceuticals, biosimilars, oncological - injectable, oncological - oral, blood products, antiviral and antiretrovirals, uterine stimulators, anaesthetics, antithrombotics, thrombolytics, female health care, antibiotics, non-beta lactams, cephalosporin, chloramphenicol, acid pumper inhibitor and other hospital products. The firm operates in Brazil, Argentina, Colombia, Peru, Uruguay, Chile and the United States, having a pharmaceutical industrial complex composed of five industrial plants, dedicated to the production of biological, biotechnological and oncological medicines, antibiotics, injectable anesthetics and biotechnological inputs.

BLAU3 Intrinsic Value
25.7 BRL
Undervaluation 50%
Intrinsic Value
Price
Back to Top